PSTX logo

Poseida Therapeutics (PSTX) Free Cash Flow

Annual FCF

-$95.23 M
-$64.54 M-210.25%

December 31, 2023


Summary


Performance

PSTX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherPSTXcash flowmetrics:

Quarterly FCF

-$10.24 M
-$47.67 M-127.35%

September 30, 2024


Summary


Performance

PSTX Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherPSTXcash flowmetrics:

TTM FCF

-$17.13 M
-$17.34 M-8178.30%

September 30, 2024


Summary


Performance

PSTX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherPSTXcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

PSTX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-210.3%-127.3%-8178.3%
3 y3 years+26.9%+75.2%+88.3%
5 y5 years-142.3%+51.2%+75.4%

PSTX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+210.2%+10.4%-117.0%+408.5%-8178.3%+635.7%
5 y5-year+210.2%+36.8%-117.0%+408.5%-8178.3%+751.9%
alltimeall time+315.9%+36.8%-117.0%+408.5%-8178.3%+751.9%

Poseida Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$10.24 M(-127.4%)
-$17.13 M(-8178.3%)
Jun 2024
-
$37.43 M(-345.2%)
$212.00 K(-100.3%)
Mar 2024
-
-$15.27 M(-47.5%)
-$71.71 M(-24.7%)
Dec 2023
-$95.23 M(+210.2%)
-$29.05 M(-509.3%)
-$95.23 M(+48.7%)
Sep 2023
-
$7.10 M(-120.6%)
-$64.04 M(+484.2%)
Jun 2023
-
-$34.49 M(-11.1%)
-$10.96 M(-37.1%)
Mar 2023
-
-$38.79 M(-1910.0%)
-$17.42 M(-43.3%)
Dec 2022
-$30.70 M(-70.8%)
$2.14 M(-96.4%)
-$30.70 M(+24.9%)
Sep 2022
-
$60.17 M(-247.0%)
-$24.58 M(-80.5%)
Jun 2022
-
-$40.95 M(-21.4%)
-$125.99 M(+7.0%)
Mar 2022
-
-$52.07 M(-730.4%)
-$117.71 M(+11.9%)
Dec 2021
-$105.18 M
$8.26 M(-120.0%)
-$105.18 M(-27.9%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$41.24 M(+26.2%)
-$145.90 M(+6.7%)
Jun 2021
-
-$32.67 M(-17.4%)
-$136.79 M(-4.6%)
Mar 2021
-
-$39.53 M(+21.8%)
-$143.37 M(+10.1%)
Dec 2020
-$130.24 M(+86.9%)
-$32.47 M(+1.1%)
-$130.24 M(+12.5%)
Sep 2020
-
-$32.13 M(-18.1%)
-$115.72 M(+10.7%)
Jun 2020
-
-$39.24 M(+48.6%)
-$104.58 M(+28.9%)
Mar 2020
-
-$26.40 M(+47.1%)
-$81.15 M(+16.5%)
Dec 2019
-$69.67 M(+77.3%)
-$17.95 M(-14.5%)
-$69.67 M(+34.7%)
Sep 2019
-
-$20.99 M(+32.8%)
-$51.72 M(+68.3%)
Jun 2019
-
-$15.81 M(+5.9%)
-$30.74 M(+105.9%)
Mar 2019
-
-$14.93 M
-$14.93 M
Dec 2018
-$39.30 M(+71.6%)
-
-
Dec 2017
-$22.90 M
-
-

FAQ

  • What is Poseida Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Poseida Therapeutics?
  • What is Poseida Therapeutics annual FCF year-on-year change?
  • What is Poseida Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Poseida Therapeutics?
  • What is Poseida Therapeutics quarterly FCF year-on-year change?
  • What is Poseida Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Poseida Therapeutics?
  • What is Poseida Therapeutics TTM FCF year-on-year change?

What is Poseida Therapeutics annual free cash flow?

The current annual FCF of PSTX is -$95.23 M

What is the all time high annual FCF for Poseida Therapeutics?

Poseida Therapeutics all-time high annual free cash flow is -$22.90 M

What is Poseida Therapeutics annual FCF year-on-year change?

Over the past year, PSTX annual free cash flow has changed by -$64.54 M (-210.25%)

What is Poseida Therapeutics quarterly free cash flow?

The current quarterly FCF of PSTX is -$10.24 M

What is the all time high quarterly FCF for Poseida Therapeutics?

Poseida Therapeutics all-time high quarterly free cash flow is $60.17 M

What is Poseida Therapeutics quarterly FCF year-on-year change?

Over the past year, PSTX quarterly free cash flow has changed by -$47.67 M (-127.35%)

What is Poseida Therapeutics TTM free cash flow?

The current TTM FCF of PSTX is -$17.13 M

What is the all time high TTM FCF for Poseida Therapeutics?

Poseida Therapeutics all-time high TTM free cash flow is $212.00 K

What is Poseida Therapeutics TTM FCF year-on-year change?

Over the past year, PSTX TTM free cash flow has changed by -$17.34 M (-8178.30%)